Ping Wang1, Zhuoya Ma2, Jingjing Tong3, Ruizhen Zhao2, Wei Shi3, Sangjie Yu3, Kaihu Yao3, Yuejie Zheng2, Yonghong Yang4. 1. Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatrics Research Institute, Beijing Children's Hospital Affiliated to Capital Medical University, Nan Lishi Road, Beijing 100045, China; Department of Pediatrics, Beijing Obstetrics and Gynecology Hospital and Beijing Maternal and Child Health Care Hospital, Affiliated to Capital Medical University, Beijing, China. 2. Laboratory of Bacteriology and Department of Respiratory Diseases, Shenzhen Children's Hospital, Shenzhen, China. 3. Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatrics Research Institute, Beijing Children's Hospital Affiliated to Capital Medical University, Nan Lishi Road, Beijing 100045, China. 4. Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatrics Research Institute, Beijing Children's Hospital Affiliated to Capital Medical University, Nan Lishi Road, Beijing 100045, China. Electronic address: yyh628628@sina.com.
Abstract
BACKGROUND: Group B Streptococcus (GBS) is an important neonatal pathogen associated with high morbidity and mortality in developed countries. However, data describing neonatal GBS disease in developing countries, particularly in Asia, are largely incomplete. The aim of this study was to determine the serotype distribution, antimicrobial resistance, and molecular characteristics of invasive GBS isolates recovered from Chinese neonates. METHODS: From 2008 to 2013, 40 GBS isolates were recovered from infected neonates less than 3 months of age. All isolates were identified with the CAMP test and commercially available techniques. Serotyping was performed by latex agglutination. Antibiotic susceptibility was tested with Etest strips and the disk diffusion method. Multilocus sequence typing and erythromycin resistance gene detection (ermB and mefA) were performed by PCR. RESULTS: Four serotypes were identified. Serotype III (85%) was the most prevalent, followed by Ia (7.5%), Ib (5%), and V (2.5%). All isolates were sensitive to penicillin, ceftriaxone, and levofloxacin. However, resistance to erythromycin (92.5%), clindamycin (87.5%), and tetracycline (100%) was observed. Among erythromycin-resistant isolates, 73.0% carried the ermB gene alone, 5.4% carried the mefA gene alone, and 21.6% expressed both ermB and mefA genes. A total of seven sequence types (STs) were identified; the most prevalent was ST17, accounting for 80% of all isolates. Further, serotype III isolates contained ST17 (94.2%), ST19 (2.9%), and ST650 (2.9%). CONCLUSION: Serotype distribution, antimicrobial susceptibility, and sequence type characterization in Asia and in other global regions may contribute to improve the prevention and treatment of neonatal GBS infections.
BACKGROUND:Group B Streptococcus (GBS) is an important neonatal pathogen associated with high morbidity and mortality in developed countries. However, data describing neonatal GBS disease in developing countries, particularly in Asia, are largely incomplete. The aim of this study was to determine the serotype distribution, antimicrobial resistance, and molecular characteristics of invasive GBS isolates recovered from Chinese neonates. METHODS: From 2008 to 2013, 40 GBS isolates were recovered from infected neonates less than 3 months of age. All isolates were identified with the CAMP test and commercially available techniques. Serotyping was performed by latex agglutination. Antibiotic susceptibility was tested with Etest strips and the disk diffusion method. Multilocus sequence typing and erythromycin resistance gene detection (ermB and mefA) were performed by PCR. RESULTS: Four serotypes were identified. Serotype III (85%) was the most prevalent, followed by Ia (7.5%), Ib (5%), and V (2.5%). All isolates were sensitive to penicillin, ceftriaxone, and levofloxacin. However, resistance to erythromycin (92.5%), clindamycin (87.5%), and tetracycline (100%) was observed. Among erythromycin-resistant isolates, 73.0% carried the ermB gene alone, 5.4% carried the mefA gene alone, and 21.6% expressed both ermB and mefA genes. A total of seven sequence types (STs) were identified; the most prevalent was ST17, accounting for 80% of all isolates. Further, serotype III isolates contained ST17 (94.2%), ST19 (2.9%), and ST650 (2.9%). CONCLUSION: Serotype distribution, antimicrobial susceptibility, and sequence type characterization in Asia and in other global regions may contribute to improve the prevention and treatment of neonatal GBS infections.
Authors: Tran Quang Hanh; Vu Van Du; Pham Thu Hien; Duong Dinh Chinh; Cao Ba Loi; Nguyen Manh Dung; Do Ngoc Anh; Tran Thi Kieu Anh Journal: Iran J Microbiol Date: 2020-02
Authors: Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag Journal: Clin Infect Dis Date: 2017-11-06 Impact factor: 20.999
Authors: Neal J Russell; Anna C Seale; Megan O'Driscoll; Catherine O'Sullivan; Fiorella Bianchi-Jassir; Juan Gonzalez-Guarin; Joy E Lawn; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Paul T Heath; Kirsty Le Doare; Shabir A Madhi; Craig E Rubens; Stephanie Schrag; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Samir K Saha; Margaret Ip Journal: Clin Infect Dis Date: 2017-11-06 Impact factor: 9.079
Authors: Menagah Ezhumalai; AbdulRahman Muthanna; Zarizal Suhaili; Nurul Diana Dzaraly; Syafinaz Amin-Nordin; Mohammad Noor Azmai Amal; Mohd Nasir Mohd Desa Journal: Malays J Med Sci Date: 2020-02-27